ArticleJournal of experimental & clinical cancer research : CR2019

Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway.

Jian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.